Literature DB >> 8518097

End-stage kidneys are capable of increased erythropoietin production.

K Morris1, M Coulthard.   

Abstract

A relative deficiency of erythropoietin (EPO) is the most important factor responsible for the anaemia of end-stage renal failure. Patients on continuous ambulatory peritoneal dialysis usually maintain a higher haemoglobin concentration than patients on other forms of dialysis. The precise mechanism is uncertain, and there is disagreement over the role of increased EPO production. An 11-year-old boy with end-stage renal failure maintained on overnight cycling peritoneal dialysis developed a reticulocytosis, followed by a marked increase in haemoglobin concentration, shortly after his dialysis schedule was altered to include a full peritoneal cavity during the daytime. This improvement in erythropoiesis was closely associated with an increase in serum EPO concentration. We suggest that the alteration in dialysis may have resulted in enhanced clearance of an inhibitor of EPO production and discuss the possible mechanisms involved.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8518097     DOI: 10.1007/BF00853219

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  19 in total

1.  Hepatitis-related hepatic erythropoietin production.

Authors:  D K Klassen; J L Spivak
Journal:  Am J Med       Date:  1990-11       Impact factor: 4.965

2.  Relation of serum erythropoietin levels to renal excretory function: evidence for lowered set point for erythropoietin production in chronic renal failure.

Authors:  M Chandra; G K Clemons; M I McVicar
Journal:  J Pediatr       Date:  1988-12       Impact factor: 4.406

3.  Release of erythropoietin from macrophages mediated by phagocytosis of crystalline silica.

Authors:  I N Rich; B Kubanek
Journal:  J Reticuloendothel Soc       Date:  1982-01

4.  Hemodialysis and continuous ambulatory peritoneal dialysis effects on erythropoiesis in renal failure.

Authors:  R J McGonigle; F Husserl; J D Wallin; J W Fisher
Journal:  Kidney Int       Date:  1984-02       Impact factor: 10.612

5.  Haemolysis in chronic renal failure.

Authors:  A B Shaw
Journal:  Br Med J       Date:  1967-04-22

6.  Erythropoietin titers in anemic, nonuremic patients.

Authors:  A J Erslev; J Wilson; J Caro
Journal:  J Lab Clin Med       Date:  1987-04

7.  Evidence that inhibition of erythropoiesis is important in the anemia of chronic renal failure.

Authors:  S F Wallner; R M Vautrin
Journal:  J Lab Clin Med       Date:  1981-02

8.  Effect of different modes of dialysis on serum erythropoietin levels in pediatric patients. A report of the Southwest Pediatric Nephrology Study Group.

Authors:  B S Beckman; J W Brookins; R K Shadduck; K F Mangan; L J Deftos; J W Fisher
Journal:  Pediatr Nephrol       Date:  1988-10       Impact factor: 3.714

9.  Haemoglobin concentration and serum erythropoietin in renal dialysis and transplant patients.

Authors:  G P Summerfield; O H Gyde; A M Forbes; H J Goldsmith; A J Bellingham
Journal:  Scand J Haematol       Date:  1983-04

10.  The hematological response to continuous ambulatory peritoneal dialysis.

Authors:  D Saltissi; G A Coles; J A Napier; P Bentley
Journal:  Clin Nephrol       Date:  1984-07       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.